RWE in Europe – An Analysis
Keywords: Patient relevant outcomes, Real word data, Regulation, Market access, Real world evidenceRead More
Major Cardiovascular Consequences of Familial Hypercholesterolemia in Poland from the Economic Perspective
Keywords: stroke, hypercholesterolemia, cost of illness, myocardial infarction, peripheral arterial diseaseRead More
VaxigripTetra (Quadrivalent Influenza Vaccine) – evidence for clinical and economic benefits from vaccination in population aged 65 and over in Poland
Keywords: elderly, influenza, vaccination, VaxigripTetra, quadrivalent influenza vaccine, cost-effectivenessRead More
Mepolizumab: a new drug programme for patients with severe eosinophilic asthma
Keywords: omalizumab, reslizumab, severe asthma, drug programme, benralizumab, mepolizumabRead More
COST-EFFECTIVENESS ANALYSIS OF METHODS OF DIAGNOSIS OF TB INFECTION IN RUSSIAN REGIONS BY USE OF RECOMBINANT TB ALLERGEN IN CHILDREN AND ADOLESCENTS.
Keywords: diagnostics, diaskintest, recombinant tuberculosis allergen, tuberculosis, cost-effectiveness analysisRead More
Patients' opinions on metoprolol, as expressed on the Internet - an exploratory, qualitative study
Keywords: quality use of medicines; Internet; qualitative study; Poland; patient safetyRead More
Environmental Determinant of Acute Diarrheal Disease among Under five Children: Unmatched Case Control Study in Babile District, East Hararghe Zone, Oromia Region, East Ethiopia
Keywords: waste disposal pit, Acute diarrheal, improved toilet facility, improved water source, Under five childrenRead More
Nutritional management in patients with gastrointestinal tumors in the surgical department
Keywords: clinical nutrition, cachexia, gastrointestinal cancers, malnutritionRead More
Cancer immunotherapy in second-line treatment of non-small cell lung cancer – is there a need to change the approach to the assessment of clinical benefits?
Keywords: non-conventional patterns of response, non-small-cell lung cancer, immune checkpoint inhibitors, immunotherapyRead More
Journal of Health Policy & Outcomes Research (JHPOR) is a peer-reviewed, international scientific journal, covering health policy, pharmacoeconomics and outcomes research in Poland and worldwide. The journal is issued under the auspices of the Polish Society of Pharmacoeconomics. It is published twice a year in electronic form, optionally in the paper version. All of the articles are published under the Open Access model. Our goal is to facilitate communication between researchers and health care policy makers by offering an outlet for discussion and dialogue.
JHPOR’s scope includes following topics:
- Clinical Trials (Phase 1-4)
- Health-Related Quality of Life
- Patient-Reported Outcomes (PRO)
- Health Technology Assessment
- Pharmacoeconomics Analyses
- Comparative Effectiveness Research
- Health Policy Analysis in Poland and around the World
- Budget Impact Analyses
- Decision Making and Management in Health Care
- Health Insurance
Meet all the experts comprising our Editorial Board, Editorial Advisory Board and ReviewersContact us
Journal of Health Policy & Outcomes Research (JHPOR) is a peer-reviewed, international scientific journal, covering health policy, pharmacoeconomics and outcomes research in Poland and worldwide. The journal is issued under the auspices of the Polish Society of Pharmacoeconomics.
Subscribe to our newsletter: